Systemic Redox Status of Rats Treated with Different Doses of Perfluorocarbon Based Blood Substitute- Perftoran®
, , , , , , , , , , e
20 set 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 20 set 2022
Pagine: 209 - 216
Ricevuto: 13 ago 2022
Accettato: 25 ago 2022
DOI: https://doi.org/10.2478/sjecr-2022-0034
Parole chiave
© 2022 Morozova Elena et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Elena, Morozova
Department of Human PathologyMoscow, Russian Federation
Sergey, Vorobyev
Department of Human PathologyMoscow, Russian Federation
Sergey, Bolevich
Department of Human PathologyMoscow, Russian Federation
Stefani, Bolevich
Department of Human PathologyMoscow, Russian Federation
Alexander, Saltykov
Department of Human PathologyMoscow, Russian Federation
Alexandra, Orlova
Department of Human PathologyMoscow, Russian Federation
Tatiana, Sinelnikova
Department of Human PathologyMoscow, Russian Federation
Maria, Kruglova
Department of Human PathologyMoscow, Russian Federation
Bella, Morgan
Department of Human PathologyMoscow, Russian Federation
Anastasia, Mikhaleva
Department of Human PathologyMoscow, Russian Federation
Alexander, Khitrov
Department of Human PathologyMoscow, Russian Federation
Jakovljevic, Vladimir
Department of Human PathologyMoscow, Russian Federation
University of Kragujevac, Faculty of Medical Sciences, Department of PhysiologyKragujevac, Serbia